GADOBUTROL
Generic: GADOBUTROL
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
GADOBUTROLActive Substance
2023-09-08Original Approval
GADOBUTROL is FDA application ANDA216081, sponsored by HENGRUI PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
143 reports
2
PRURITUS
132 reports
3
NAUSEA
126 reports
4
URTICARIA
106 reports
5
VOMITING
87 reports
6
ERYTHEMA
83 reports
7
DIZZINESS
81 reports
8
HYPOTENSION
78 reports
9
COUGH
68 reports
10
RASH
66 reports